TY  - JOUR
AU  - Ramalingam, Suresh S
AU  - Novello, Silvia
AU  - Guclu, Salih Zeki
AU  - Bentsion, Dmitry
AU  - Zvirbule, Zanete
AU  - Szilasi, Maria
AU  - Bernabe, Reyes
AU  - Syrigos, Konstantinos
AU  - Byers, Lauren Averett
AU  - Clingan, Philip
AU  - Bar, Jair
AU  - Vokes, Everett E
AU  - Govindan, Ramaswamy
AU  - Dunbar, Martin
AU  - Ansell, Peter
AU  - He, Lei
AU  - Huang, Xin
AU  - Sehgal, Vasudha
AU  - Glasgow, Jaimee
AU  - Bach, Bruce A
AU  - Mazieres, Julien
PY  - 2021
DO  - 10.1200/JCO.20.03318
UR  - https://hdl.handle.net/10668/27336
T2  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
AB  - Squamous non-small-cell lung cancer (sqNSCLC) is genetically complex with evidence of DNA damage. This phase III study investigated the efficacy and safety of poly (ADP-ribose) polymerase inhibitor veliparib in combination with conventional...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Benzimidazoles
KW  - Biomarkers, Tumor
KW  - Carboplatin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Clinical Decision-Making
KW  - Female
KW  - Gene Expression Profiling
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Patient Selection
KW  - Progression-Free Survival
KW  - Smokers
KW  - Time Factors
KW  - Transcriptome
TI  - Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
TY  - research article
VL  - 39
ER  -